TobaccoReporter logo

Tag: Nicotine Pouches

  • 20mg of Nicotine Per Pouch Optimal, Expert Says

    20mg of Nicotine Per Pouch Optimal, Expert Says

    Haypp’s senior director of scientific affairs, Dr. Marina Murphy, touts the benefits of nicotine pouches as an alternative to smoking, and recommends a maximum nicotine strength of 20mg per pouch to ensure these products serve as an effective harm-reduction tool. This recommendation comes as U.K. lawmakers continue to navigate progress toward a smoke-free future, with pouches growing in popularity. The 20mg dosage, Murphy says, provides an experience comparable to a cigarette, encouraging adult smokers to switch while avoiding the risks associated with ultra-strong products — some that reach 150mg per pouch.

    The 20mg limit aligns with Swedish and British industry standards and sets a clear, understandable benchmark for consumers and retailers, she says. Murphy says that by incorporating this limit into U.K. regulations, the government can make nicotine pouches a viable, safer alternative to cigarettes, balancing public health objectives with adult consumer choice, and supporting the country’s broader smoke-free goals.

  • Haypp Launches Caffeine Pouches

    Haypp Launches Caffeine Pouches

    Haypp Group expanded its product lineup with the launch of caffeine pouches across its online retail platforms, adding a new category to its nicotine-free offerings. The company said the products — available across its websites in the U.K. and Scandinavian markets — are designed to provide consumers with a discreet, portable way to manage caffeine intake without drinks or preparation, with a range of strengths and flavors.

    Haypp said the move reflects growing demand for functional wellness and on-the-go products, particularly among professionals and fitness-focused consumers seeking convenient alternatives to coffee or energy drinks. The retailer expects the addition to strengthen its position in the expanding oral pouch segment and plans to promote the launch through a U.K. tour featuring a mobile sampling truck.

    On Jan. 1, Haypp exited the UK’s vape and heated tobacco markets to focus exclusively on oral pouches.

  • Macau Proposes Tougher E-Cigarette, Tobacco Rules

    Macau Proposes Tougher E-Cigarette, Tobacco Rules

    The Health Bureau (SSM) unveiled five proposals to strengthen Macau’s Smoking Prevention and Control Law, targeting youth and emerging products. Key measures include banning public possession of e-cigarettes, prohibiting nicotine pouches, shisha, and herbal cigarettes, and introducing standardized packaging with 85% health warnings.

    The proposals, aimed at curbing smuggling and teen appeal, also allow frontline monitors to use body cameras during inspections and open a public consultation period from March 8 to April 8. The SSM emphasized that these measures build on the 2012 law and the 2018 amendments to protect public health.

  • Report Examines Power of Pouches for Women’s Cessation

    Report Examines Power of Pouches for Women’s Cessation

    In advance of International Women’s Day on March 8, Smoke Free Sweden released its Empowerment in a Pouch report, focused on encouraging women to quit smoking by using alternative nicotine products. The report says women often face unique challenges with smoking cessation, including stronger behavioral cues linked to stress, weight management, and social contexts. As a result, many women have adopted alternatives such as e-cigarettes in attempts to reduce or replace cigarette use, drawn by features such as reduced odor, perceived lower health risks compared with combustible cigarettes, and the ability to use them discreetly in daily life. Surveys in several markets indicate that women who vape frequently cite convenience, control over nicotine intake, and the absence of smoke as key factors influencing their choice.

    The report also discusses how access to tobacco-free nicotine pouches has accelerated Sweden’s progress towards becoming smoke-free, particularly among women. The report was sent to governments around the world as policymakers, researchers, and health organizations continue to debate how alternative products affect women’s health, smoking cessation trends, and long-term nicotine dependence across different populations.

    “Sweden’s experience shows what happens when women are given realistic alternatives to smoking,” said Professor Marewa Glover, behavioral scientist and co-author. “When safer options are accessible, women quit in large numbers. If those options are restricted, progress slows, and smoking persists.”

  • Tech Offices Offering Nicotine Pouches as Workplace Perk

    Tech Offices Offering Nicotine Pouches as Workplace Perk

    A report in Fortune highlights a growing trend among some technology companies that are placing nicotine pouches in office vending machines as a workplace perk, with the aim of boosting employee focus and productivity. At the Washington, D.C., office of Palantir Technologies, vending machines stocked with nicotine pouches from startups Lucy Nicotine and Sesh Products have been installed for employees and guests over the age of 21. According to reports cited by The Wall Street Journal, the products are provided free of charge and paid for by the company.

    The practice is also appearing at smaller tech firms. Hello Patient, an AI-powered healthcare startup based in Austin, experimented with a nicotine-pouch fridge in its office after its founder noticed engineers using the products during work.

    The article also notes that researchers at the University of Texas MD Anderson Cancer Center said that while nicotine pouches are smoke-free, they still deliver nicotine and can lead to dependence, underscoring the ongoing debate about the health implications of workplace nicotine use.

  • Haypp Releases New Guidance on Nicotine Pouches

    Haypp Releases New Guidance on Nicotine Pouches

    Online nicotine retailer Haypp has voluntarily adopted a 20 mg per pouch cap across its e-commerce platforms and is urging the UK government to formalize that as the limit as it develops a regulatory framework under its Tobacco and Vapes Bill. The company, which serves more than 1.1 million customers globally, says proportionate limits would protect consumers while preserving nicotine pouches as a viable reduced-risk alternative to cigarettes. Dr. Marina Murphy, Haypp’s senior director of scientific affairs, said a 20 mg maximum provides a nicotine experience comparable to smoking without enabling “ultra-strength” products to proliferate, with some reportedly containing up to 150 mg per pouch.

  • Pouch Boom Disrupting Scandinavian Tradition: Report

    A report tracking more than 19 million online purchases between 2018 and 2025 suggests nicotine pouches are rapidly overtaking traditional snus in Sweden and Norway, signaling a cultural shift in Scandinavia’s long-standing oral nicotine market. The research found that tobacco-free nicotine pouches now account for the largest share of oral nicotine sales on leading regional e-commerce platforms, as consumers move away from tobacco-based snus. Globally, nicotine pouch sales have surged from roughly 292 million units in 2018 to more than 20 billion in 2023, with strong growth also reported in the UK and U.S. Study co-author Dr. Marina Murphy of Haypp Group said many users perceive pouches as a lower-risk alternative, underscoring the need for public health authorities to closely monitor the fast-evolving category and its broader implications.

  • New York Gov. Floats 75% Tax on Nicotine Pouches

    New York Gov. Floats 75% Tax on Nicotine Pouches

    New York Gov. Kathy Hochul’s executive budget proposes applying the state’s existing 75% wholesale tobacco tax to nicotine pouches. The proposal comes as state tobacco tax revenue declined from about $1 billion in 2021 to roughly $793 million last year, while cigarette smuggling — estimated to account for more than half of cigarettes consumed in New York — costs the state about $812 million annually, according to Tax Foundation data. State health data show nicotine pouch use among New York high school students increased from 1.5% in 2022 to 3% in 2025. The tax proposal is under consideration as part of budget negotiations.

  • FDA Releases Meeting Materials for Zyn’s MRTP Application  

    FDA Releases Meeting Materials for Zyn’s MRTP Application  

    Today (January 20), the U.S. Food and Drug Administration released meeting materials ahead of a virtual meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) to review modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 Zyn nicotine pouch products. The materials include a draft agenda, background documents from both the applicant and the FDA, and draft questions for committee consideration, and are available on the FDA’s 2026 TPSAC Meeting Materials and Information page.

    The virtual TPSAC meeting is scheduled for January 22. FDA opened Docket No. FDA-2025-N-0835-0020  for public comments related to the meeting, with submissions due by 11:59 p.m. ET on January 21. Comments specific to the ZYN MRTP applications may also be submitted under a separate docket, Docket No. FDA-2025-N-0835-0001, which was established on June 18, 2025.

    Visit the event webpage to learn more about attending the meeting online

  • Doseology Partners with McKinney to Bring Pouches to Market

    Doseology Partners with McKinney to Bring Pouches to Market

    Doseology Sciences entered a strategic partnership with McKinney Regulatory Science Advisors to guide its U.S. regulatory strategy as it advances oral pouch products toward commercial readiness. Under the agreement, McKinney will advise on formulation strategy, data generation, PMTA preparation, and post-market compliance, positioning Doseology to navigate FDA requirements while strengthening product design and intellectual property protection.

    The company said the collaboration marks a shift from development to regulatory execution, with a focus on dose consistency, consumer safety, and compliance in regulated markets. McKinney’s regulatory roadmap will be integrated into Doseology’s R&D and manufacturing validation plans, supporting structured PMTA readiness for both nicotine and nicotine-analogue products as the company seeks to establish a defensible, science-led position in the oral pouch category.